Skip to main content

Advertisement

Figure 3 | BMC Health Services Research

Figure 3

From: The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients

Figure 3

Average health plan and patient paid health care costs (annualized baseline and 12 month follow-up). For health plan paid costs, differences in costs between baseline and follow-up were statistically significant (p < 0.001) for all categories, with the exception of ER costs (p = 0.653). For patient paid costs, differences in costs between baseline and follow-up were statistically significant (p < 0.001) for all categories, with the exception of total costs (p = 0.989) and ER costs (p = 0.758). Bars represent standard deviation.

Back to article page